Stock A174900 ABCLON INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company AbClon Inc.

Equities

A174900

KR7174900001

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-06-02 pm EDT 		5-day change 1st Jan Change
17,050 KRW +0.06% Intraday chart for AbClon Inc. -12.65% +15.05%
2023 AbClon Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
2023 AbClon Presents Non-Clon and Phase 1 Interim Results of its AT101 Novel CAR-T Therapy at the Annual 2023 AACR Conference CI

Business Summary

AbClon Inc. is a Korea-based company principally engaged in the development, manufacture and distribution of antibody drug. The Company developed a bio synergy antibody, a therapeutic antibody for a new mechanism that is different from conventional therapeutic agents, and is based on the YPLUS and AffiMab platforms. The company's products include AC101, AC103, AC104, AC106, AC203, AM201, AM101, AM102 and AM103. The Company distributes its products within domestic market and to overseas markets.

Sales per Business

KRW in Million2022Weight2023Weight Delta
Antibody Drugs
100.0 %
3,406 100.0 % 3,083 100.0 % -9.50%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
99.5 %
3,398 99.8 % 3,066 99.5 % -9.77%
Others
0.5 %
7 0.2 % 16 0.5 % +128.19%

Managers

Managers TitleAgeSince
Jong-Seo Lee FOU
 Founder 61 10-06-24
Young-Jin Hwang DFI
 Director of Finance/CFO 51 -
Gyu-Tae Kim CTO
 Chief Tech/Sci/R&D Officer 57 -
Hee-Soo Lee AUD
 Comptroller/Controller/Auditor 60 -

Members of the board

Members of the board TitleAgeSince
Jong-Seo Lee FOU
 Founder 61 10-06-24
Yong-Jun Lee BRD
 Director/Board Member 54 22-02-21
Jae-Won Lee BRD
 Director/Board Member 54 -
Jung-Ho Kim BRD
 Director/Board Member 60 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 17,214,182 14,725,799 ( 85.54 %) 0 85.54 %
Stock B 0 395,360 0 0

Shareholders

NameEquities%Valuation
Jong-Seo Lee
8.535 %
1,401,675 8.535 % 17 M ₩
Seung-ryul Lee
5.115 %
840,000 5.115 % 10 M ₩
Quad Investment Management Co., Ltd.
2.081 %
341,748 2.081 % 4 M ₩
Won-hwan Kim
0.8524 %
140,000 0.8524 % 2 M ₩
Hye-sun Park
0.6150 %
101,000 0.6150 % 1 M ₩
Kiwoom Asset Management Co., Ltd.
0.0865 %
14,200 0.0865 % 169 627 ₩
Samsung Asset Management Co., Ltd.
0.001273 %
209 0.001273 % 2 497 ₩
Mirae Asset Global Investments Co., Ltd.
0.000767 %
126 0.000767 % 1 505 ₩
NH-Amundi Asset Management Co., Ltd.
0.000426 %
70 0.000426 % 836 ₩
Jung-Ho Kim
0.000000 %
0 0.000000 % - ₩

Company contact information

AbClon, Inc.

Unit 1401, Ace Twin Tower 1 285 Digital-ro

08381, Seoul

+

http://www.abclon.com
address AbClon Inc.(A174900)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per region

Sector Biopharmaceuticals

1st Jan change Capi.
ABCLON INC. Stock AbClon Inc.
+15.05% 214M
CSL LIMITED Stock CSL Limited
-1.62% 90.85B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
-1.05% 39.02B
BIOGEN INC. Stock Biogen Inc.
-10.60% 33.46B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-19.90% 14.51B
INCYTE CORPORATION Stock Incyte Corporation
-5.74% 13.22B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-11.42% 11.65B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-47.67% 10.57B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+6.52% 9.23B
ALTEOGEN INC. Stock ALTEOGEN Inc.
+102.03% 7.71B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. A174900 Stock
  4. Company AbClon Inc.